Unknown

Dataset Information

0

Comparison of different endoscopic resection techniques for submucosal tumors originating from muscularis propria at the esophagogastric junction.


ABSTRACT: BACKGROUND:To compare the outcomes of submucosal tunneling endoscopic resection (STER) and submucosal excavation (ESE) for the treatment of submucosal tumors (SMTs) arising from the muscularis propria (MP) at the esophagogastric junction (EGJ). METHODS:A retrospective analysis of patients with SMTs at EGJ who underwent STER and ESE from October 2011 to October 2017 was performed. The outcomes evaluated were operation time, complete resection rate, adverse events, and tumor recurrence. RESULTS:Ninety patients were included in this study. Complete resection rates in the STER group were higher than those of the ESE group (100 vs. 92%, p < 0.05). For tumors ?15?mm, both techniques achieved 100% complete resection rate; but for tumors >?15?mm, complete resection rate was higher in the STER group than the ESE group (100% vs. 77.8%, p < 0.05). Subgroup analyses revealed that the operation time of STER for in cardiac-gastric group was longer than that for ESE (145.14?±?42.43?min vs. 70.32?±?39.84?min, p??15?mm, STER is the preferred choice due to its higher complete resection rate.

SUBMITTER: Xu HW 

PROVIDER: S-EPMC6833169 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Comparison of different endoscopic resection techniques for submucosal tumors originating from muscularis propria at the esophagogastric junction.

Xu Hong-Wei HW   Zhao Qi Q   Yu Shu-Xia SX   Jiang Ying Y   Hao Jing-Hua JH   Li Bin B  

BMC gastroenterology 20191106 1


<h4>Background</h4>To compare the outcomes of submucosal tunneling endoscopic resection (STER) and submucosal excavation (ESE) for the treatment of submucosal tumors (SMTs) arising from the muscularis propria (MP) at the esophagogastric junction (EGJ).<h4>Methods</h4>A retrospective analysis of patients with SMTs at EGJ who underwent STER and ESE from October 2011 to October 2017 was performed. The outcomes evaluated were operation time, complete resection rate, adverse events, and tumor recurre  ...[more]

Similar Datasets

| S-EPMC10788014 | biostudies-literature
| S-EPMC7455822 | biostudies-literature
| S-EPMC4607707 | biostudies-literature
| S-EPMC4423268 | biostudies-other
| S-EPMC7430816 | biostudies-literature
| S-EPMC4648854 | biostudies-literature
| S-EPMC11348501 | biostudies-literature
| S-EPMC9478042 | biostudies-literature
| S-EPMC8759939 | biostudies-literature
| S-EPMC6669323 | biostudies-literature